Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Morcamilast- Meiji Seika Pharma

Next Previous
Drug Profile

Morcamilast- Meiji Seika Pharma

Alternative Names: ME-3183

Latest Information Update: 06 Mar 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Meiji Seika Pharma
  • Class Anti-inflammatories; Antipsoriatics; Skin disorder therapies; Small molecules
  • Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Palmoplantar pustulosis
  • New Molecular Entity Yes
  • Available For Licensing Yes - Palmoplantar pustulosis

Highest Development Phases

  • Phase II Plaque psoriasis

Most Recent Events

  • 03 Mar 2026 Morcamilast- Meiji Seika Pharma is available for licensing as of 03 Mar 2026. www.meiji.com
  • 03 Mar 2026 ME 3183 receives Orphan Drug status for Palmoplantar pustulosis in European Union
  • 16 Oct 2023 Safety and efficacy data from a phase IIa trial in Plaque psoriasis released by Meiji Seika Pharma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top